Recombinant Nampt Monoclonal Antibody

Dodavatel: Reddot Biotech USA Inc.
Teplota skladování: Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles.
Katalogové číslo:
RD86988A/50
50μL
6 182,00 Kč
NA OBJEDNÁNÍ
RD86988A/100
100μL
10 046,00 Kč
NA OBJEDNÁNÍ
Velikost balení:
Cena bez DPH:
Dostupnost:
Vložit do košíku
Zobrazovat ceny: bez DPH / včetně DPH
This is a Recombinant Nampt Recombinant Antibody from Reddot Biotech. This product is for Research Use Only.
Nicotinamide phosphoribosyltransferase(NAMPT) has two usual synonyms termed Visfatin and PBEF. Its primary role is to catalyze the condensation of nicotinamide with 5-phosphoribosyl-1-pyrophosphate to yield nicotinamide mononucleotide,an intermediate in the biosynthesis of NAD,which is the rate limiting component in the mammalian NAD biosynthesis pathway. NAMPT is localized in cytoplasm and expressed in large amounts in bone marrow,liver tissue,and muscle tissues. NAMPT inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. NAMPT levels are altered in plasma of patients with type 2 diabetes mellitus (T2DM),and it is now evidenced that NAMPT may plays a role in lipid metabolism.
ClonalityMonoclonal
Purification MethodAffinity purification
IsotypeIgG
HostRabbit
ImmunogenA synthetic peptide of human Visfatin
Gene ID10135
SwissprotP43490
Calculated MW160kDa
Observed MW160kDa
ReactivityHuman,Mouse,Rat
ApplicationsWB,IHC-P
ConjugationUnconjugated
DilutionWB 1:500-1:1000, IHC 1:50-1:100
Concentration300 μg/mL
Buffer50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40% Glycerol, 0.01% Sodium azide and 0.05% protective protein
0
RD86988A/100